首页> 外文期刊>Frontiers in Medicine >Effect of Point Spread Function Deconvolution in Reconstruction of Brain 18 F-FDG PET Images on the Diagnostic Thinking Efficacy in Alzheimer's Disease
【24h】

Effect of Point Spread Function Deconvolution in Reconstruction of Brain 18 F-FDG PET Images on the Diagnostic Thinking Efficacy in Alzheimer's Disease

机译:点传播功能去卷积对大脑18 F-FDG PET图像重建的影响 - 阿尔茨海默病的诊断思想疗效

获取原文
           

摘要

Purpose: This study aims to determine the effect of applying Point Spread Function (PSF) deconvolution, which is known to improve contrast and spatial resolution in brain 18 F-FDG PET images, to the diagnostic thinking efficacy in Alzheimer's disease (AD). Methods: We compared Hoffman 3-D brain phantom images reconstructed with or without PSF. The effect of PSF deconvolution on AD diagnostic clinical performance was determined from digital brain 18 F-FDG PET images of AD ( n = 38) and healthy ( n = 35) subjects compared to controls ( n = 36). Performances were assessed with SPM at the group level ( p 0.001 for the voxel) and at the individual level by visual interpretation of SPM T-maps ( p 0.005 for the voxel) by the consensual analysis of three experienced raters. Results: A mix of large hypometabolic (1,483cm 3 , mean value of ?867 ± 492 Bq/ml) and intense hypermetabolic (902 cm 3 , mean value of 1,623 ± 1,242 Bq/ml) areas was observed in the PSF compared to the no PSF phantom images. Significant hypometabolic areas were observed in the AD group compared to the controls, for reconstructions with and without PSF (respectively 23.7 and 26.2 cm 3 ), whereas no significant hypometabolic areas were observed when comparing the group of healthy subjects to the control group. At the individual level, no significant differences in diagnostic performances for discriminating AD were observed visually (sensitivity of 89 and 92% for reconstructions with and without PSF respectively, similar specificity of 74%). Conclusion: Diagnostic thinking efficacy performances for diagnosing AD are similar for 18 F-FDG PET images reconstructed with or without PSF.
机译:目的:本研究旨在确定应用点扩散功能(PSF)去卷积的效果,这已知已知提高大脑18 F-FDG PET图像中的对比度和空间分辨率,以促进阿尔茨海默病(AD)的诊断思想疗效。方法:我们将重建的Hoffman 3-D脑幻影图像与没有PSF进行比较。与对照相比,从数字脑18(n = 38)和健康(n = 35)受试者的数字脑18 f-fdg PET图像测定PSF去卷积对AD诊断临床表现的影响。通过SPM在组水平(P <0.001对于体素的P <0.001)和各种水平来评估性能,通过对三种经历的三种经历的评估者的同意分析,通过对SPM T型图(P <0.005的P <0.005)进行个体水平。结果:在PSF中,在PSF中观察到大型乳房抑制的混合物(1,483℃,α867±492bq / ml)和强烈的超代谢(902cm 3,平均值为1,623±1,242bq / ml)区域。没有psf phantom图像。与对照相比,在AD组中观察到显着的低次衰减区域,用于使用和没有PSF的重建(分别为23.7和26.2cm 3),而在将对照组的健康受试者组比较时,没有观察到任何显着的低低聚区域。在个体层面,目测观察到视觉上观察到鉴别广告的诊断性能的显着差异(对于89和92%的敏感性,与并且没有PSF的重建,类似的特异性为74%)。结论:诊断诊断诊断疗效表现对于重建的18个F-FDG宠物图像类似于或没有PSF的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号